๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

10 recruiting trials

for Astrocytoma, IDH-Mutant, Grade 3

Intracranial Genetically Modified Immune Cells (TGFฮฒR2KO/IL13Rฮฑ2 CAR T-Cells) for the Treatment of Recurrent or Progressive Glioblastoma or Grade 3 or 4 IDH-Mutant Astrocytoma NCT06815029Phase 11 site๐Ÿ“ Duarte City of Hope Medical Center ยท Tests: Biospecimen Collection, Chimeric Antigen Receptor T-Cell Therapy, Echocardiography, Fludeoxyglucose F-18, Intracranial โ€ฆ Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer NCT07215910Phase 3152 sites๐Ÿ“ Bakersfield๐Ÿ“ Duarte๐Ÿ“ Dublin Alliance for Clinical Trials in Oncology ยท Tests: Intensity-Modulated Radiation Therapy, Volume Modulated Arc Therapy, Pencil Beam Scanning, Intensity-Modulated Proton Tโ€ฆ Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas NCT07468136Phase 1, Phase 21 site๐Ÿ“ Rochester Mayo Clinic ยท Tests: Biospecimen Collection, Eflornithine, Lumbar Puncture, Magnetic Resonance Imaging, Retifanlimab Vorasidenib Maintenance for IDH Mutant Astrocytoma NCT06809322Phase 359 sites๐Ÿ“ Bedford Park๐Ÿ“ Camperdown๐Ÿ“ Heidelberg European Organisation for Research and Treatment of Cancer โ€ฆ ยท Tests: Vorasidenib, Vorasidenib Placebo The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201) NCT06118723n/a8 sites๐Ÿ“ San Francisco๐Ÿ“ Boston๐Ÿ“ Leuven Jasper Gerritsen ยท Tests: Supramaximal resection, Maximal safe resection PRO-GLIO: PROton Versus Photon Therapy in IDH-mutated Diffuse Grade II and III GLIOmas NCT05190172NA1 site๐Ÿ“ Oslo Oslo University Hospital ยท Tests: Radiation therapy Safety and Efficacy Study of Safusidenib in Participants With IDH1-Mutant Glioma Who Discontinued Vorasidenib Treatment Due to Progressive Disease NCT07703436Phase 212 sites๐Ÿ“ Los Angeles๐Ÿ“ San Francisco๐Ÿ“ New Haven Nuvation Bio Inc. ยท Tests: Safusidenib SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance) NCT05303519Phase 361 sites๐Ÿ“ Birmingham๐Ÿ“ Phoenix๐Ÿ“ Phoenix Nuvation Bio Inc. ยท Tests: safusidenib, Placebo A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma NCT05765812Phase 1, Phase 216 sites๐Ÿ“ Chicago๐Ÿ“ New York๐Ÿ“ New York Debiopharm International SA ยท Tests: Debio 0123, Temozolomide, Radiotherapy Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma NCT06860594Phase 143 sites๐Ÿ“ Duarte๐Ÿ“ Irvine๐Ÿ“ La Jolla National Cancer Institute (NCI) ยท Tests: Biospecimen Collection, Computed Tomography, Intensity-Modulated Radiation Therapy, Magnetic Resonance Imaging, Triapine
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy